Barely Significant
← all excerpts

Short-term (24 weeks) treatment efficacy and safety of ruxolitinib cream in participants with vitiligo: a systematic review and meta-analysis.

Syst Rev · 2024 · PMC11445846 · PMID 39358803

0
hedged sentences
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.